POU2F3 and carcinoma: We also detected POU2F3 immunoreactivity in mucoepidermoid (1/2) and lymphoepithelial (2/2) carcinomas of the thymus, which to our knowledge is the first immunohistochemical detection of POU2F3 in these carcinoma subtypes.